EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
March 31, 2026 -1.202
December 31, 2025 -1.483
September 30, 2025 -1.81
June 30, 2025 -1.786
March 31, 2025 -1.777
December 31, 2024 -1.661
September 30, 2024 -1.528
June 30, 2024 -1.623
March 31, 2024 -1.601
December 31, 2023 -1.555
September 30, 2023 -1.465
June 30, 2023 -1.380
March 31, 2023 -1.380
Date Value
December 31, 2022 -1.366
September 30, 2022 -1.438
June 30, 2022 -1.370
March 31, 2022 -1.248
December 31, 2021 -1.103
September 30, 2021 -0.8768
June 30, 2021 -0.7372
March 31, 2021 -0.592
December 31, 2020 -0.519
September 30, 2020 -0.3636
June 30, 2020 -0.222
March 31, 2020 -0.1095

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Stoke Therapeutics, Inc. -2.842
Agenus, Inc. 1.670
Amgen, Inc. 14.38
BioCryst Pharmaceuticals, Inc. -1.776
Imunon, Inc. -5.167